What are PROCEPT BioRobotics Corporation's total assets?

PROCEPT BioRobotics Corporation (PRCT) holds $487.1M in total assets, down 6.2% year over year.

How much debt does PROCEPT BioRobotics Corporation have?

PROCEPT BioRobotics Corporation carries $78.0M in total debt against $347.7M of shareholders' equity, a debt-to-equity ratio of 0.22.

How much cash does PROCEPT BioRobotics Corporation have?

PROCEPT BioRobotics Corporation holds $12.2M in cash and equivalents.

Can PROCEPT BioRobotics Corporation cover its short-term obligations?

Its current ratio is 6.73 — current assets exceed current liabilities.

Where does PROCEPT BioRobotics Corporation's balance sheet data come from?

Every line is extracted from PROCEPT BioRobotics Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

PROCEPT BioRobotics Corporation PRCT Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$12.23M-96.2%	$11.42M-96.6%	$297.32M+48.8%	$305.76M+40.8%	$319.25M+39.6%
Restricted cash	$3.04M0.0%	$3.04M0.0%	$3.04M0.0%	$3.04M0.0%	$3.04M0.0%
Accounts receivable, net	$345.24M+18.8%	$328.12M+22.6%	$328.08M+41.2%	$312.63M+57.9%	$290.73M+68.8%
Inventories	$77.54M+24.4%	$70.69M+25.9%	$66.72M+31.2%	$67.03M+52.8%	$62.33M+49.8%
Raw materials	$23.33M+21.5%	$18.62M+2.4%	$18.39M+29.6%	$17.08M-6.8%	$19.2M+19.0%
Work in process	$12.83M+17.7%	$13.45M+17.4%	$12.81M+35.1%	$12.96M+346%	$10.9M+689%
Finished goods	$41.37M+28.3%	$38.63M+45.6%	$35.51M+30.7%	$36.99M+63.5%	$32.23M+33.7%
Prepaid expenses and other current assets	$8.47M+6.0%	$9.65M+14.1%	$9.25M+46.4%	$7.5M+49.5%	$7.99M+35.2%
Total current assets	$428.03M-8.1%	$450.38M-6.5%	$454.75M+40.8%	$458.07M+42.3%	$465.79M+41.5%
Property and equipment, net	$31.74M+12.8%	$30.4M+13.8%	$30.02M+12.8%	$28.6M+3.3%	$28.13M-1.3%
Accumulated depreciation	$14.42M+57.1%	$12.75M+62.9%	$12.2M+79.9%	$10.65M+79.4%	$9.18M+91.1%
Operating lease right-of-use assets	$17.16M-7.8%	$17.54M-7.4%	$17.9M-7.1%	$18.26M-6.8%	$18.61M-6.5%
Goodwill	$640K-25.9%	$709K-23.9%	$727K-27.3%	$795K-25.6%	$864K-23.9%
Other non-current assets	$6.45M+119%	$6.02M+136%	$5.1M+308%	$4.29M+293%	$2.95M+154%
Total assets	$487.06M-6.2%	$508.08M-4.9%	$511.54M+36.7%	$513.05M+37.1%	$519.38M+35.6%
Accounts payable	$59.04M+18.3%	$55.01M+21.8%	$47.76M-1.8%	$51.73M+9.8%	$49.9M+5.7%
Accrued expenses	$10.25M+20.9%	$10.07M+24.5%	$8.18M+3.6%	$9.69M+25.1%	$8.48M+11.2%
Accrued compensation	$18.48M+23.4%	$23.18M+7.6%	$21.8M+15.7%	$16.3M+9.5%	$14.98M+30.6%
Deferred revenue	$13.7M+39.8%	$13.05M+36.4%	$10.67M+33.5%	$9.89M+50.9%	$9.8M+67.2%
Current portion of long-term debt	——	——	——	——	——
Operating lease liabilities, current	$2.36M+18.9%	$2.21M+15.9%	$2.14M+16.1%	$2.06M+16.4%	$1.98M+16.6%
Total current liabilities	$63.64M+22.2%	$65.8M+23.8%	$53.9M+0.5%	$49.73M+16.1%	$52.06M+34.7%
Long-term debt	$51.66M+0.3%	$51.62M+0.3%	$51.57M+0.2%	$51.52M+0.2%	$51.5M+0.2%
Operating lease liabilities, non-current	$23.97M-9.0%	$24.65M-8.2%	$25.23M-7.8%	$25.78M-7.4%	$26.33M-7.0%
Operating Lease Liabilities (Total)	$26.33M-7.0%	$26.87M-6.6%	$27.36M-6.3%	$27.84M-6.0%	$28.32M-5.7%
Other non-current liabilities	$121K-62.7%	$147K-54.6%	$576K+20.3%	$223K—	$324K—
Total liabilities	$139.4M+7.0%	$142.21M+7.9%	$131.27M-1.2%	$127.26M+3.8%	$130.22M+9.6%
Preferred stock	$0—	$0—	$0—	$0—	$0—
Common stock	300M0.0%	300M—	300M0.0%	300M0.0%	300M0.0%
Additional paid-in capital	$1.02B+6.4%	$1.01B+6.3%	$991.95M+29.1%	$976.24M+28.8%	$959.66M+28.9%
Retained earnings	-$673.2M-18.0%	-$641.56M-17.5%	-$611.71M-16.0%	-$590.3M-16.6%	-$570.72M-18.8%
Accumulated other comprehensive income (loss)	-$19K-109%	$37K-67.5%	$42K+333%	-$144K-14,300%	$223K+97.3%
Total stockholders' equity	$347.67M-10.7%	$365.87M-9.0%	$380.28M+57.6%	$385.8M+53.2%	$389.16M+47.4%
Total liabilities and stockholders' equity	$487.06M-6.2%	$508.08M-4.9%	$511.54M+36.7%	$513.05M+37.1%	$519.38M+35.6%
Allowance for Doubtful Accounts	$1.25M—	$1.06M—	$2.27M—	——	——
Allowance for Doubtful Accounts Receivable (Current)	$1.25M—	$1.06M—	$2.27M—	——	——
Lease Receivable Payments - 2022 (Lessor)	——	——	——	——	——
Lease Receivable Payments - 2023 (Lessor)	——	——	——	——	——
Lease Receivable Payments - 2024 (Lessor)	——	——	——	——	——
Lease Receivable Payments - 2025 (Lessor)	——	——	——	——	——
Lease Receivable Payments - Remainder of Fiscal Year	——	——	——	——	——
Total Lease Receivable Payments	——	——	——	——	——
Lease Receivable Payments - Due Year Two	——	——	——	——	——
Lease Receivable Payments - Due Year Three	——	——	——	——	——
Deferred Tax Assets and Other Non-Current Assets	$6.45M+119%	$6.02M+136%	$5.1M+308%	$4.29M+293%	$2.95M+154%
Goodwill and Intangible Assets, Net	$640K-25.9%	$709K-23.9%	$727K-27.3%	$795K-25.6%	$864K-23.9%
Lease Receivable Payments - 2026 (Lessor)	——	——	——	——	——
Lease Receivable Payments - 2027 (Lessor)	——	——	——	——	——
Net Investment in Lease	$5.48M+120%	$4.8M+187%	$5.02M-74.0%	$3.95M-79.9%	$2.49M-87.5%
Goodwill and intangible assets, net	$640K-25.9%	$709K-23.9%	$727K-27.3%	$795K-25.6%	$864K-23.9%
Operating lease right-of-use assets	$17.16M-7.8%	$17.54M-7.4%	$17.9M-7.1%	$18.26M-6.8%	$18.61M-6.5%
Other non-current assets	$6.45M+119%	$6.02M+136%	$5.1M+308%	$4.29M+293%	$2.95M+154%
Property, plant and equipment at cost	$46.16M+23.7%	$43.15M+24.9%	$42.22M+26.5%	$39.25M+16.8%	$37.3M+12.1%
Operating Lease Right-of-Use Assets in Other Assets	$17.16M-7.8%	$17.54M-7.4%	$17.9M-7.1%	$18.26M-6.8%	$18.61M-6.5%
Software and Technology Licenses, Net	$6.45M+119%	$6.02M+136%	$5.1M+308%	$4.29M+293%	$2.95M+154%
Other accrued liabilities	$10.25M+20.9%	$10.07M+24.5%	$8.18M+3.6%	$9.69M+25.1%	$8.48M+11.2%
Finance Lease Liability Payments Due	——	——	——	——	——
Lease Liability Payments - 2020 (Remaining Three Months)	——	——	——	——	——
Operating Lease Liability Payments - 2024 (Lessee)	——	——	——	——	——
Operating Lease Liability Payments - 2025 (Lessee)	——	——	——	——	——
Lease Liability Payments - Due Year Two	——	——	——	——	——
Lease Liability Payments - Due Year Three	——	——	——	——	——
Lease Liability Payments - Due Year Four	——	——	——	——	——
Lease Liability Payments - Remainder of Fiscal Year	——	——	——	——	——
Operating Lease Liability Payments Due	——	——	——	——	——
Operating Lease Liability - Undiscounted Excess Amount	——	——	——	——	——
Debt Maturity - 2027	——	——	——	——	——
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	——	——	——	——	——
Operating Lease Liability Payments - 2026 (Lessee)	——	——	——	——	——
Operating Lease Liability Payments - 2027 (Lessee)	——	——	——	——	——
Operating Lease Liability Payments - 2028 (Lessee)	——	——	——	——	——
Total debt	$78M-11.8%	$78.48M-2.2%	$78.93M-2.1%	$79.37M-2.0%	$88.48M+8.7%
Total Carrying Value of Debt	——	——	——	——	——
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	56.9M+2.9%	56.3M+2.9%	55.9M+7.1%	55.6M+7.1%	55.3M+7.6%
Convertible Preferred Stock Authorized Shares	10M0.0%	10M0.0%	10M0.0%	10M0.0%	10M0.0%
Convertible Preferred Stock Issued Shares	0—	0—	0—	0—	0—
Convertible Preferred Stock Outstanding Shares	0—	0—	0—	0—	0—
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$0—	$0—	$0—	$0—	$0—
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—	$0—
Number of Exercisable Options	$44.7M-72.5%	$61M-74.6%	$79.8M-70.6%	$154.8M-24.0%	$162.3M-3.6%
Number of Vested and Expected to Vest Options	$44.7M-73.7%	$61M-76.7%	$79.8M-73.4%	$159.2M-30.2%	$170M-10.6%
Preferred Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Share-Based Payment - Unrecognized Cost of Nonvested Awards	——	——	——	——	——
Cumulative Cost Basis	$46.16M+23.7%	$43.15M+24.9%	$42.22M+26.5%	$39.25M+16.8%	$37.3M+12.1%
Accounts Receivable, Allowance for Credit Loss	$1.25M—	$1.06M—	$2.27M—	——	——
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$300M0.0%	$300M0.0%	$300M0.0%	$300M0.0%	$300M0.0%
Common stock, shares issued (in shares)	$56.9M+2.9%	$56.32M+2.9%	$55.87M+7.1%	$55.58M+7.1%	$55.28M+7.6%
Common Stock, Shares, Outstanding	$56.9M+2.9%	$56.32M+2.9%	$55.87M+7.1%	$55.58M+7.1%	$55.28M+7.6%
Long-term debt, gross	——	——	——	——	——
Debt Instrument, Unamortized Discount (Premium), Net	——	——	——	——	——
Unrecognized compensation cost related to non-vested awards	——	——	——	——	——
Raw materials	$23.33M+21.5%	$18.62M+2.4%	$18.39M+29.6%	$17.08M-6.8%	$19.2M+19.0%
Lessee Operating Lease Liability Payments Due	——	——	——	——	——
Thereafter	——	——	——	——	——
Lessee Operating Lease Liability Undiscounted Excess Amount	——	——	——	——	——
2028	——	——	——	——	——
2027	——	——	——	——	——
Preferred Stock, Par or Stated Value Per Share	$00.0%	$00.0%	$00.0%	$00.0%	$00.0%
Preferred Stock, Shares Authorized	$10M0.0%	$10M0.0%	$10M0.0%	$10M0.0%	$10M0.0%
Preferred Stock, Shares Issued	$0—	$0—	$0—	$0—	$0—
Preferred Stock, Shares Outstanding	$0—	$0—	$0—	$0—	$0—
2028	——	——	——	——	——
Sales-Type and Direct Financing Leases, Payment to be Received	——	——	——	——	——
Remainder of 2026	——	——	——	——	——
2027	——	——	——	——	——
2029	——	——	——	——	——
2030 and thereafter	——	——	——	——	——
Sales-Type Lease, Net Investment in Lease, before Allowance for Credit Loss	$4.78M—	$4.8M—	$4.08M—	——	——
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value	$44.7M-73.7%	$61M-76.7%	$79.8M-73.4%	$159.2M-30.2%	$170M-10.6%
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value	$44.7M-72.5%	$61M-74.6%	$79.8M-70.6%	$154.8M-24.0%	$162.3M-3.6%
Remainder of Fiscal Year 2024	——	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about PROCEPT BioRobotics Corporation.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are PROCEPT BioRobotics Corporation's total assets?: PROCEPT BioRobotics Corporation (PRCT) holds $487.1M in total assets, down 6.2% year over year.
How much debt does PROCEPT BioRobotics Corporation have?: PROCEPT BioRobotics Corporation carries $78.0M in total debt against $347.7M of shareholders' equity, a debt-to-equity ratio of 0.22.
How much cash does PROCEPT BioRobotics Corporation have?: PROCEPT BioRobotics Corporation holds $12.2M in cash and equivalents.
Can PROCEPT BioRobotics Corporation cover its short-term obligations?: Its current ratio is 6.73 — current assets exceed current liabilities.
Where does PROCEPT BioRobotics Corporation's balance sheet data come from?: Every line is extracted from PROCEPT BioRobotics Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.